• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Redburn Atlantic initiated coverage on Medpace

    10/14/24 9:24:58 AM ET
    $MEDP
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $MEDP alert in real time by email
    Redburn Atlantic initiated coverage of Medpace with a rating of Buy
    Get the next $MEDP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MEDP

    DatePrice TargetRatingAnalyst
    6/24/2025$300.00Equal Weight
    Barclays
    4/22/2025Outperform → Mkt Perform
    William Blair
    4/14/2025$328.00Buy → Hold
    TD Cowen
    3/24/2025$330.00Market Perform
    Leerink Partners
    10/23/2024$413.00 → $349.00Outperform → Neutral
    Robert W. Baird
    10/14/2024Buy
    Redburn Atlantic
    9/27/2024$420.00 → $350.00Buy → Neutral
    UBS
    9/25/2024$415.00 → $345.00Buy → Hold
    Jefferies
    More analyst ratings

    $MEDP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Medpace with a new price target

      Barclays initiated coverage of Medpace with a rating of Equal Weight and set a new price target of $300.00

      6/24/25 8:08:46 AM ET
      $MEDP
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Medpace downgraded by William Blair

      William Blair downgraded Medpace from Outperform to Mkt Perform

      4/22/25 10:17:27 AM ET
      $MEDP
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Medpace downgraded by TD Cowen with a new price target

      TD Cowen downgraded Medpace from Buy to Hold and set a new price target of $328.00

      4/14/25 8:14:21 AM ET
      $MEDP
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care